Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
Journal of the Advanced Practitioner in Oncology|April 4, 2022
Cardiovascular Adverse Events and Mitigation Strategies for Chronic Myeloid Leukemia Patients Receiving Tyrosine Kinase Inhibitor TherapyLisa Nodzon, Anecita Fadol, Sara Tinsley
Journal of the Advanced Practitioner in Oncology|October 19, 2018
Practical Strategies for Management of Lenalidomide-Associated Cytopenias in Myelodysplastic Syndromes With del(5q)Sandra E Kurtin, Jean A Ridgeway, Sara Tinsley
Journal of the Advanced Practitioner in Oncology|June 15, 2018
Practical Guide to Bone Marrow Sampling for Suspected Myelodysplastic SyndromesJean A Ridgeway, Sara Tinsley, Sandra E Kurtin
Clinical Journal of Oncology Nursing|May 30, 2012
Management of transfusion-related iron overload in patients with myelodysplastic syndromesJayshree Shah, Sandra E Kurtin, Louise Arnold, et al.
Journal of Human Lactation : Official Journal of International Lactation Consultant Association|August 30, 2019
Growth and Change in the Journal of Human Lactation: A Content Analysis 1985-2018Ethan T Bamberger, Aimee R Eden, Kathleen A Marinelli, et al.
American Journal of Hematology|April 26, 2014
Phase II clinical study of erlotinib for treatment of myelodysplastic syndromesRami S Komrokji, Eric Padron, Daohai Yu, et al.
Clinical Lymphoma, Myeloma & Leukemia|March 11, 2019
Lenalidomide and Prednisone in Low and Intermediate-1 IPSS Risk, Non-Del(5q) Patients With Myelodysplastic Syndromes: Phase 2 Clinical TrialRami S Komrokji, Najla H Al Ali, Eric Padron, et al.
International Journal of Hematology|October 5, 2014
Increased genomic instability may contribute to the development of kinase domain mutations in chronic myeloid leukemiaKendra Sweet, Najla H Al Ali, Samir M Dalia, et al.
Clinical Lymphoma, Myeloma & Leukemia|March 28, 2024
Triple-Negative Myelofibrosis: Disease Features, Response to Treatment and OutcomesLuis E Aguirre, Akriti Jain, Somedeb Ball, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|November 27, 2012
Quality of life outcomes in patients with chronic myeloid leukemia treated with tyrosine kinase inhibitors: a controlled comparisonKristin M Phillips, Javier Pinilla-Ibarz, Eduardo Sotomayor, et al.
Pageof 3